HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colo-rectal carcinoma in a tropical African population: an overview report.

Abstract
Fifty-one selected cases of colo-ano-rectal carcinoma seen in a tropical African population over a period of two decades were reviewed. The patients were divided into three groups. Group A were those cases seen under the age of thirty years, Group B were the resectable rectal carcinoma because they were bulky and occupied the whole of the pelvis. This we referred to as cases with "frozen" pelvis. Our modality of treatment consists of surgical excision when possible, the use of Levamisole, the use of 5-Fluoro-Uracil either intravenously, intraperitonealy and intrarectally as the case requires and radiotherapy when available. For Group A, the average survival period is 10.6 months, for Group B, it is 17.3 months and for Group C, it is 14.5 months. Symptoms of tenesmus and ascites improved by intrarectal and intraperitoneal infusion of calculated dose of 5-Fluoro-Uracil.
AuthorsO G Ajao, I A Grillo, T Malatani, M Y al Shehri
JournalEast African medical journal (East Afr Med J) Vol. 71 Issue 10 Pg. 640-3 (Oct 1994) ISSN: 0012-835X [Print] Kenya
PMID7821242 (Publication Type: Journal Article)
Chemical References
  • Levamisole
  • Fluorouracil
Topics
  • Adenocarcinoma (drug therapy, radiotherapy, surgery, therapy)
  • Administration, Rectal
  • Adolescent
  • Adult
  • Aged
  • Anus Neoplasms (drug therapy, radiotherapy, surgery, therapy)
  • Ascites (drug therapy)
  • Colonic Neoplasms (drug therapy, radiotherapy, surgery, therapy)
  • Combined Modality Therapy
  • Defecation
  • Female
  • Fluorouracil (administration & dosage, therapeutic use)
  • Humans
  • Injections, Intraperitoneal
  • Injections, Intravenous
  • Levamisole (therapeutic use)
  • Male
  • Middle Aged
  • Nigeria
  • Rectal Neoplasms (drug therapy, radiotherapy, surgery, therapy)
  • Survival Rate
  • Treatment Outcome
  • Tropical Climate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: